,
Shoji, Tadahiro
Komiyama, Shinichi
Kigawa, Junzo
Tanabe, Hiroshi
Kato, Kazuyoshi
Itamochi, Hiroaki
Fujiwara, Hiroyuki
Kamiura, Shoji
Hamano, Tetsutaro
Sugiyama, Toru
Article History
Received: 16 February 2016
Accepted: 15 May 2018
First Online: 31 July 2018
Ethics approval and consent to participate
: Institutional review board approval has been obtained from each participating center. A full list of the ethics committees for each institution is provided in the Supplementary Information. All patients will be required to provide signed informed consent. This trial will be conducted according to the International Conference on Harmonization Guidelines for Good Clinical Practice, the Ethical Guideline for Medical and Health Research involving Human Subjects and applicable local laws and regulations.
: T.Sh. has received honoraria for lectures and manuscript writing/editing from Chugai Pharmaceutical. S. Ko., J.K., H.T., H.I., S. Ka, and T.H. have received honoraria for lectures from Chugai Pharmaceutical. H.F. and T.Su. have received honoraria for lectures and research grant from Chugai Pharmaceutical. K.K. declares that he has no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.